Pharma Sector

Indian Corporate Revenue Growth Slows: Pharma, Telecom, And Airlines Buck The Trend

Cipla Q1 Profit Jumps 10% To Rs 1,298 Crore, Revenue At Rs 6,957 Crore

Anthem Biosciences Makes Strong Stock Market Debut With Nearly 27 Per Cent Listing Premium

India’s Healthcare Sector Maintains Growth Momentum Despite Profitability Pressures

Cipla CEO Says US Drug Pricing Order Unlikely To Impact Indian Generics

Which Sectors Are Most Affected By Trump Tariffs? Find Out

India Engages With Domestic Pharma Exporters Amid US Tariff Concerns

US Tariffs Pose Minimal Threat To Indian Pharma, Says Citi; Details Here

Indian Regulator Shuts Down 36% Of Drug-Making Units: DCGI

India's Domestic Drug Formulations Market Likely To Hit Rs 5.5 Trillion Mark By 2034: Report

India's Stance On IPRs, Pharma in FTA Will Fosters Growth Of Generic Drug Sector: GTRI

Govt Rejects EU FTA's 'Data Exclusivity' Ask To Protect Generic Drug Companies' Interest